The Patent Finder

Universidad de Chile

33 patents currently held · Updated Nov 17, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

3
Ending by 2030
Sep 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 15, 2027
    The maintenance fee for Pharmaceutical compositions comprising angiotensin-(1-9), derivatives thereof, or a vector expressing ACE2, useful for treating cardiovascular, pulmonary, cerebral, and/or renal remodeling (US 9,132,164) comes due Mar 15, 2027. Unpaid by Sep 15, 2027, it lapses early.
  • 1 fee due Apr 24, 2027
    The maintenance fee for AAV/UPR-plus virus, UPR-plus fusion protein, genetic treatment method and its use in the treatment of neurodegenerative diseases, such as Parkinson's disease and Huntington's disease, among others (US 11,795,476) comes due Apr 24, 2027. Unpaid by Oct 25, 2027, it lapses early.
  • 1 fee due May 14, 2027
    The maintenance fee for Curcumin-loaded nanoemulsions, method of manufacture, and method of preventive treatment using the same (US 11,813,355) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
  • 1 fee due Jun 24, 2027
    The maintenance fee for Method for genetic treatment using the AAV-XBP1s/GFP virus and use thereof in the prevention and treatment of amyotrophic lateral sclerosis (US 10,512,698) comes due Jun 24, 2027. Unpaid by Dec 27, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,694,059Ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,050,920Biometric control method on the telephone network with speaker verification technology by using an intra speaker variability and additive noise unsupervised compensation
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,940,693Protein for the Immunocastration for Mammals
In force
 · High confidence
In forceHigh confidence
US 9,132,164Pharmaceutical compositions comprising angiotensin-(1-9), derivatives thereof, or a vector expressing ACE2, useful for treating cardiovascular, pulmonary, cerebral, and/or renal remodeling
In force
 · From the USPTO record
In forceFrom the USPTO record
US PP29,727Nectarine tree named ‘Andes Nec-2’
In force
 · From the USPTO record
In forceFrom the USPTO record
US PP25,893Nectarine tree named ‘Andes Nec-3’
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,481,800Polymeric materials with antifouling, biocidal, antiviral and antimicrobial properties; elaboration method and its uses
In force
 · From the USPTO record
In forceFrom the USPTO record
US PP26,403Nectarine denominated ‘Andes Nec-1’
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,274,677Control System and Procedure for Controlled Access by Means of an Optical Device Based on Flat Bands
In force
 · High confidence
In forceHigh confidence
US PP29,705Nectarine tree named ‘Andes Nec-4’
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 33 patents shown.
Pro members see all 33.
Pro members: see all 33 patents
Also on record, not counted in the 33: 1 patent in force now held by others · 25 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

10 pending · 3 abandoned · 20 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited